IMMUNE CHECKPOINT BLOCKADE (ICB) IN BRAIN METASTASES (BM) FROM ADVANCED SMALL CELL UROTHELIAL CANCER (ASCUC)

被引：0
|
作者：
Wilson, Nathaniel [1 ]
Alhalabi, Omar [2 ]
Hasanov, Elshad [2 ]
Xiao, Lianchun [2 ]
Papadopoulos, John [2 ]
Campbell, Matthew [2 ]
Shah, Amishi [2 ]
Gao, Jianjun [2 ]
Corn, Paul [2 ]
Aparicio, Ana [2 ]
Wang, Jennifer [2 ]
Czerniak, Bogdan [2 ]
Guo, Charles [2 ]
Logothetis, Christopher [2 ]
Li, Jing [2 ]
Choi, Seungtaek [2 ]
Tang, Chad [2 ]
Tannir, Nizar [2 ]
Siefker-Radtke, Arlene [2 ]
机构：
[1] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2021年 / 9卷
关键词：
D O I：
10.1136/jitc-2021-SITC2021.241
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
241
引用
收藏
页码：A259 / A260
页数：2
相关论文
共 50 条
  • [31] Interferon-Gamma (INFG) as a Biomarker to Guide Immune Checkpoint Blockade (ICB) in Cancer Therapy
    Karachaliou, N.
    Gonzalez Cao, M.
    Gimenez-Capitan, A.
    Drozdowskyj, A.
    Aldeguer, E.
    Teixido, C.
    Crespo, G.
    Molina-Vila, M.
    Viteri, S.
    De Los Llanos Gil, M.
    Martin Algarra, S.
    Perez-Ruiz, E.
    Marquez-Rodas, I.
    Rodriguez-Abreu, D.
    Blanco, R.
    Puertolas, T.
    Royo, M. A.
    Rosell, R.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2000 - S2000
  • [32] Immune checkpoint blockade in small cell lung cancer: is there a light at the end of the tunnel?
    Paglialunga, Luca
    Salih, Zena
    Ricciuti, Biagio
    Califano, Raffaele
    ESMO OPEN, 2016, 1 (04)
  • [33] Interferon-gamma (INFG), a predictive factor of response to immune checkpoint blockade (ICB) in melanoma and non-small cell lung cancer (NSCLC)
    Gonzalez-Cao, Maria
    Karachaliou, Niki
    Crespo, Guillermo
    Aldeguer, Erika
    Drozdowskyj, Ana
    Gimenez-Capitan, Ana
    Teixido, Cristina
    Angel Molina-Vila, Miguel
    Viteri Ramirez, Santiago
    Martin Algarra, Salvador
    Perez-Ruiz, Elisabeth
    Marquez-Rodas, Ivan
    Rodriguez-Abreu, Delvys
    Blanco, Remei
    Puertolas, Teresa
    Angeles Royo, Maria
    Rosell, Rafael
    JOURNAL OF TRANSLATIONAL MEDICINE, 2018, 16
  • [34] Peripherally measured T cell self-renewal capacity associates with response to immune checkpoint blockade (ICB) in non-small cell lung cancer (NSCLC)
    Maniar, Rohan
    Wang, Peter H.
    Washburn, Robert S.
    Rizvi, Naiyer A.
    Reiner, Steven L.
    Henick, Brian S.
    CANCER RESEARCH, 2022, 82 (12)
  • [35] Immune response in breast cancer brain metastases (BM) and their microenvironment
    Duchnowska, Renata
    Peksa, Rafal
    Radecka, Barbara
    Mandat, Tomasz
    Trojanowski, Tomasz
    Jarosz, Bozena
    Czartoryska-Ariukowicz, Bogumila
    Olszewski, Wojciech
    Och, Waldermar
    Kalinka-Warzocha, Ewa
    Kowalczyk, Anna
    Biernat, Wojciech
    Jassem, Jacek
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [36] Mismatch repair-deficient prostate cancer with parenchymal brain metastases treated with immune checkpoint blockade
    Sena, Laura A.
    Salles, Daniela C.
    Engle, Elizabeth L.
    Zhu, Qingfeng
    Tukachinsky, Hanna
    Lotan, Tamara L.
    Antonarakis, Emmanuel S.
    COLD SPRING HARBOR MOLECULAR CASE STUDIES, 2021, 7 (04):
  • [37] Immune Checkpoint Blockade in Advanced Renal-Cell Carcinoma
    Santoni, Matteo
    Montironi, Rodolfo
    Battelli, Nicola
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (01): : 91 - +
  • [38] Non-small cell lung cancer brain metastases and the immune system: From brain metastases development to treatment
    El Rassy, Elie
    Botticella, Angela
    Kattan, Joseph
    Le Pechoux, Cecile
    Besse, Benjamin
    Hendriks, Lizza
    CANCER TREATMENT REVIEWS, 2018, 68 : 69 - 79
  • [39] EGFR exon 20 insertions in non-small cell lung cancer (NSCLC): Impact of co-occurring mutations and immune checkpoint blockade (ICB)
    Kron, A.
    Scheffler, M.
    Ihle, M.
    Michels, S.
    Sueptitz, J.
    Prang, D.
    Jakobs, F.
    Nogova, L.
    Fischer, R.
    Grohe, C.
    Kaminsky, B.
    Benedikter, J.
    Ladage, D.
    Brummendorf, T.
    Krueger, S.
    Eisert, A.
    Riedel, R.
    Kron, F.
    Hillmer, A.
    Loges, S.
    Merkelbach-Bruse, S.
    Buettner, R.
    Wolf, J.
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 271 - 271
  • [40] Immune-checkpoint blockade in cisplatin-ineligible patients with urothelial cancer
    Faltas, Bishoy M.
    Tagawa, Scott T.
    LANCET, 2017, 389 (10064): : 6 - +
12345